Patients in distributive shock appear to have a lower risk for atrial fibrillation when vasopressin is added to catecholamine vasopressors, but its effect on other outcomes are mixed, according to a ...

Giapreza, a vasoconstrictor, increases blood pressure through increased aldosterone release La Jolla Pharmaceutical announced the availability of Giapreza (angiotesin II) injection for intravenous (IV ...

Angiotensin II drug to treat low blood pressure associated with septic shock has been approved by the United States Food and Drug Administration. U.S. Food and Drug Administration (USFDA) approves ...

Interim data found adding PHP/Hemoximer to vasopressor therapy increased number of deaths. A Phase III trial evaluating Curacyte’s Nitric Oxide (NO) scavenger pyridoxalated hemoglobin polyoxyethylene ...

One in eight patients hospitalized with COVID-19 develop some form of shock, according to the American Heart Association’s COVID-19 Cardiovascular Disease Registry. And regardless of whether the shock ...

Nearly two-thirds of patients with acute MI complicated by cardiogenic shock have some form of noncardiac organ failure and this complication is on the rise, according to the results of a new study.